SENIOR LEADERSHIP
SENIOR LEADERSHIP
批准号:
8709459
负责人:
Tyler J. Curiel
金额:
$7.5万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2014-07-31
关键词:
Basic ScienceBudgetsCancer CenterCancer ControlClinical ResearchClinical SciencesEducationEnsureEnvironmentEquilibriumFinancial SupportFutureGrowthHealth PromotionHispanicsIndividualInstitutesLeadershipNCI Center for Cancer ResearchPositioning AttributeRecruitment ActivityResearchResource SharingResourcesRoleSite VisitSouth TexasTimeTranslatingTranslational ResearchUnited States National Institutes of Healthauthoritycancer carecancer preventioncancer therapyexpectationmeetingsmemberoutreachpractical applicationprogramspublic trustskillssuccess
中文摘要
高级领导是具有必要技能的个人,这些技能总体上提供了一个平衡的,
全面了解我们的癌症中心,以确保其最佳增长,功能,资源利用,
方案内和方案间的互动。这些人也代表了癌症的相关方面
中心事务,以各种临床和研究实体,构成我们的矩阵环境,以确保
确保癌症中心的互动能够发挥最大的优势,并能够最好地利用现有的外部资源。
领导层包括癌症中心执行主任(Curiel博士)和副主任(Giles博士),我们的
三位科学副主任,Slaga博士(基础和转化研究),Naylor博士(共享
资源和内部教育)和波洛克博士(癌症预防和控制)。拉米雷斯博士担任
高级领导,因为她是健康促进研究所的主任,该研究所为一个
重要的癌症预防和西班牙裔外展功能为我们的癌症中心。我们还有一个临时
协理行政主任的权力大大增加,并具有明确的高级领导作用,
在审查前要求。在全国范围内寻找一名永久的行政助理主任,
undenway,预计到实地考察时,该长期职位将得到填补。的
高级领导层确保我们的癌症中心通过适当的方式履行其公众信任
管理NCI、NIH和相关机构和慈善机构的资金,将发现转化为
提供临床和研究癌症护理需求的实际应用,南圣安东尼奥
德州和国家所有高级领导成员都是执行委员会成员,
制定当前癌症中心议程的委员会,计划未来的发展,挑战和机遇
并帮助制定预算,招募人才和满足这些不同需求的科学议程。支持是
Curiel博士(50%),Giles博士(5%),Naylor博士(10%),Ramirez博士(10%),Slaga博士(20%),
女士McCarroll(50%)。一些高级领导也担任项目负责人,但通常这些职责
在财政支持方面与高级领导共同分担。因此,大多数人都支持“整体”,
这些人的努力来自高级领导层,释放了我们预算中的稀缺资源,
在我们的癌症中心有额外的建设性用途。
英文摘要
Senior Leadership are individuals with the requisite skill sets that in their totality, provide a balanced and
complete perspective on our Cancer Center to ensure its optimal growth, function, resource utilization, and
intra- and inter-programmatic interactions. These individuals also represent relevant aspects of Cancer
Center affairs to the various clinical and research entities that comprise our matrix environment to ensure
that the Cancer Center interacts to best advantage and can best capitalize on available external resources.
Leadership includes the Cancer Center Executive Director (Dr. Curiel) and Deputy Director (Dr. Giles), our
three scientific Associate Directors, Dr. Slaga (Basic and Translational Research), Dr. Naylor (Shared
Resources and Internal Education) and Dr. Pollock (Cancer Prevention and Control). Dr. Ramirez serves as
Senior Leadership owing to her directorship of the Institute for Health Promotion Research, which serves a
critical cancer prevention and Hispanic outreach function for our Cancer Center. We also have an interim
Associate Director of Administration with greatly augmented authority and a clear Senior Leadership role as
requested in the prior review. A national search for a permanent Associate Director of Administration is
undenway, with the expectation that the permanent position will be filled by the time of the site visit. The
Senior Leadership ensures that our Cancer Center discharges its public trust through appropriate
stewardship of NCI, NIH and related, institutional and philanthropic dollars to translate discoveries into
practical applications that provide for the clinical and research cancer care needs of San Antonio, South
Texas and the nation. All Senior Leadership members sit on the Executive Committee and other important
committees that set current Cancer Center agendas, plan for future growth, challenges and opportunities
and help set budgets, recruiting pnorities and scientific agendas that meet these various needs. Support is
requested for Dr. Curiel (50%), Dr. Giles (5%), Dr. Naylor (10%), Dr. Ramirez (10%), Dr. Slaga (20%), and
Ms. McCarroll (50%). Some Senior Leadership also serve as Program Leaders, but generally those duties
are co-shared with Senior Leadership in terms of financial support. Thus, most support for the totality'of the
efforts of these individuals comes from Senior Leadership, freeing our scare resources in the budget for
additional, constructive uses in our Cancer Center.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
-
批准号:10467877
-
项目类别:
-
资助金额:$64.67万
-
财政年份:2022
-
负责人:Tyler J. Curiel
-
依托单位:
Bladder cancer PD-L1 control of homologous recombination: Basic mechanisms applied to novel treatments
-
批准号:10688261
-
项目类别:
-
资助金额:$62.07万
-
财政年份:2022
-
负责人:Tyler J. Curiel
-
依托单位:
Regulation of ER-beta Signaling in Carcinogenesis
-
批准号:10092967
-
项目类别:
-
资助金额:$48.43万
-
财政年份:2019
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
-
批准号:9788318
-
项目类别:
-
资助金额:$53.01万
-
财政年份:2018
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
-
批准号:10381324
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2018
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
-
批准号:10475260
-
项目类别:
-
资助金额:$60.15万
-
财政年份:2018
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ2) PD-L1/PD-1 signals in aged hosts undergoing cancer immunotherapy
-
批准号:10247570
-
项目类别:
-
资助金额:$56.53万
-
财政年份:2018
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
-
批准号:9926828
-
项目类别:
-
资助金额:$64.05万
-
财政年份:2017
-
负责人:Tyler J. Curiel
-
依托单位:
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
-
批准号:9307468
-
项目类别:
-
资助金额:$65.08万
-
财政年份:2017
-
负责人:Tyler J. Curiel
-
依托单位:
Immune aspects of mTOR inhibition for cancer prevention (PQ5)
-
批准号:8538910
-
项目类别:
-
资助金额:$15.28万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
B7-H1 Signaling in Ovarian Cancer
-
批准号:8535695
-
项目类别:
-
资助金额:$29.16万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
Immune aspects of mTOR inhibition for cancer prevention (PQ5)
-
批准号:8383608
-
项目类别:
-
资助金额:$19.51万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
B7-H1 Signaling in Ovarian Cancer
-
批准号:8693606
-
项目类别:
-
资助金额:$30.09万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
B7-H1 Signaling in Ovarian Cancer
-
批准号:8871691
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
B7-H1 Signaling in Ovarian Cancer
-
批准号:8372230
-
项目类别:
-
资助金额:$31.0万
-
财政年份:2012
-
负责人:Tyler J. Curiel
-
依托单位:
PLANNING AND EVALUATION
-
批准号:7944703
-
项目类别:
-
资助金额:$2.23万
-
财政年份:2009
-
负责人:Tyler J. Curiel
-
依托单位:
SENIOR LEADERSHIP
-
批准号:7944695
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2009
-
负责人:Tyler J. Curiel
-
依托单位:
CAREER DEVELOPMENT
-
批准号:7944716
-
项目类别:
-
资助金额:$4.14万
-
财政年份:2009
-
负责人:Tyler J. Curiel
-
依托单位:
ANTIBODY
-
批准号:7944722
-
项目类别:
-
资助金额:$2.74万
-
财政年份:2009
-
负责人:Tyler J. Curiel
-
依托单位:
CANCER PREVENTION AND POPULATION SCIENCES
-
批准号:7944718
-
项目类别:
-
资助金额:$4.44万
-
财政年份:2009
-
负责人:Tyler J. Curiel
-
依托单位:
海外基金